nach oben

Journal of Diabetes & Metabolic Disorders

Erschienen in:

02.05.2021 | Commentary

Ramadan fasting and diabetes, latest evidence and technological advancements: 2021 update

verfasst von: Ali Tootee, Bagher Larijan

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Development of updated guidelines for management of diabetes in Ramadan Fasting is of paramount importance. Nonetheless, evidence-based guidelines in the field of Ramadan Fasting and Diabetes are scarce. Moreover, findings of some recent research such as effects of Ramadan fasting on microbiota, genetics and epigenetics, hormonal changes (such as adiponectin, leptin, testosterone…), and alternations in circadian rhythm should also be reviewed and included on a yearly basis. It is documented that self-monitoring of blood glucose (SMBG) is of vital importance for patients with type 1 diabetes who fast, and advantages of continuous glucose monitoring (CGM) or flash glucose monitoring (FGM) techniques should be highlighted. Moreover, the recent findings about applications of advanced insulin delivery technology in patients with diabetes who fast in Ramadan should also considered in the annual updates of the guidelines.

IDF Diabetes Atlas. International Diabetes Federation Brussels, Belgium; (2019).

Ghani F. Most Muslims say they fast during Ramadan. (2013).

Ahmad S, Shukla AK, Shrama S, Pant B, Tripathi MK. Effects of Ramadan Fasting on Social, Psychological and Physical Well Being to Health. International Journal of Contemporary Microbiology. 2015;1(2):25–9.CrossRef

Salti I, Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004;27(10):2306–11.PubMedCrossRef

Hassanein M, Abdelgadir E, Bashier A, Rashid F, Al Saeed M, Khalifa A, et al. The role of optimum diabetes care in form of Ramadan focused diabetes education, flash glucose monitoring system and pre-Ramadan dose adjustments in the safety of Ramadan fasting in high risk patients with diabetes. Diabetes Res Clin Pract. 2019;150:288–95.PubMedCrossRef

Tourkmani AM, Alharbi TJ, Rsheed AMB, AlRasheed AN, AlBattal SM, Abdelhay O, et al. Impact of Ramadan Focused Education Program on medications adjustment for patients with type 2 diabetes in a primary health care institution in Saudi Arabia. Diabetes Metab Syndr. 2019;13(1):161–5.PubMedCrossRef

Benaji B, Mounib N, Roky R, Aadil N, Houti I, Moussamih S, et al. Diabetes and Ramadan: review of the literature. Diabetes Res Clin Pract. 2006;73(2):117–25.PubMedCrossRef

Bravis V, Hui E, Salih S, Mehar S, Hassanein M, Devendra D. Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan. Diabet Med. 2010;27(3):327–31.PubMedCrossRef

Haghdoost A, Poorranjbar M. The interaction between physical activity and fasting on the serum lipid profile during Ramadan. (2009).

10.

Ann W. Recognizing & Treating Hypoglycemia, Hyperglycemia & Other Diabetes-related Health Problems.

11.

UK D. Hypos and hypers. (2017).

12.

Hassanein M, Alamoudi RM, Kallash M-A, Aljohani NJ, Alfadhli EM, El Tony L, et al. Ramadan fasting in people with type 1 diabetes during COVID-19 pandemic: The DaR Global survey. diabetes research and clinical practice. (2021);172:108626.

13.

Loh HH, Lim LL, Loh HS, Yee A. Safety of Ramadan fasting in young patients with type 1 diabetes: A systematic review and meta-analysis. Journal of diabetes investigation. 2019;10(6):1490–501.PubMedPubMedCentralCrossRef

14.

Bin-Abbas BS. Insulin pump therapy during Ramadan fasting in type 1 diabetic adolescents. Ann Saudi Med. 2008;28(4):305–6.PubMedPubMedCentralCrossRef

15.

Cameron FJ, Amin R, De Beaufort C, Codner E, Acerini CL. Diabetes in adolescence Pediatric diabetes. 2014;15:245–56.PubMedCrossRef

16.

Miller VA, Xiao R, Slick N, Feudtner C, Willi SM. Youth Involvement in the Decision to Start CGM Predicts Subsequent CGM Use. Diabetes Care. 2020;43(10):2355–61.PubMedCrossRef

17.

Bonakdaran S, Khajeh-Dalouie M. The effects of fasting during Ramadan on glycemic excursions detected by continuous glucose monitoring system (CGMS) in patients with type 2 diabetes. Med J Malaysia. 2011;66(5):447–50.PubMed

18.

Lessan N, Hannoun Z, Hasan H, Barakat M. Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: insights from continuous glucose monitoring (CGM). Diabetes Metab. 2015;41(1):28–36.PubMedCrossRef

19.

Kaplan W, Afandi B, Al Hassani N, Hadi S, Zoubeidi T. Comparison of continuous glucose monitoring in adolescents with type 1 diabetes: Ramadan versus non-Ramadan. Diabetes Res Clin Pract. 2017;134:178–82.PubMedCrossRef

20.

Afandi B, Kaplan W, Majd L, Roubi S. Rate, timing, and severity of hypoglycemia in adolescents with type 1 diabetes during Ramadan fasting: a study with freestyle libre flash glucose monitoring system. Ibnosina Journal of Medicine and Biomedical Sciences. 2018;10(1):9.CrossRef

21.

Eltoum N, Washi S, Al Twaim A. Dietary habits and nutrients intake of diabetic adolescents during Ramadan fasting. International Journal of Food, Nutrition and Public Health. (2014);7(1).

22.

Deeb A, Elbarbary N, Smart CE, Beshyah SA, Habeb A, Kalra S, et al. ISPAD Clinical Practice Consensus Guidelines: Fasting during Ramadan by young people with diabetes. Pediatr Diabetes. 2020;21(1):5–17.PubMedCrossRef

23.

Bell KJ, Smart CE, Steil GM, Brand-Miller JC, King B, Wolpert HA. Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era. Diabetes Care. 2015;38(6):1008–15.PubMedCrossRef

24.

Ibrahim M, Al Magd MA, Annabi FA, Assaad-Khalil S, Ba-Essa EM, Fahdil I, et al. Recommendations for management of diabetes during Ramadan: update 2015. BMJ Open Diabetes Res Care. 2015;3(1):e000108.PubMedPubMedCentralCrossRef

25.

Al-Khawari M, Al-Ruwayeh A, Al-Doub K, Allgrove J. Adolescents on basal-bolus insulin can fast during Ramadan. Pediatr Diabetes. 2010;11(2):96–100.PubMedCrossRef

26.

Danne T, Bangstad HJ, Deeb L, Jarosz-Chobot P, Mungaie L, Saboo B, et al. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(S20):115–34.PubMedCrossRef

27.

Al-Arouj M, Assaad-Khalil S, Buse J, Fahdil I, Fahmy M, Hafez S, et al. Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care. 2010;33(8):1895–902.PubMedCrossRef

28.

Hassanein M, Al-Arouj M, Hamdy O, Bebakar WMW, Jabbar A, Al-Madani A, et al. Diabetes and Ramadan: practical guidelines. Diabetes Res Clin Pract. 2017;126:303–16.PubMedCrossRef

29.

Afandi B, Kaplan W, Al Hassani N, Hadi S, Mohamed A. Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes. J Endocrinol Invest. 2017;40(7):741–4.PubMedCrossRef

30.

AlAlwan I, Al BA. effects of Ramadan fasting on children with type 1 diabetes. International Journal of Diabetes Mellitus. 2010;2(2):127–9.CrossRef

31.

Smart CE, King BR, Lopez PE. Insulin dosing for fat and protein: is it time? Diabetes Care. 2020;43(1):13–5.PubMedCrossRef

32.

Beshyah SA. Fasting during the month of Ramadan for people with diabetes: medicine and Fiqh united at last. Ibnosina J Med Biomed Sci. 2009;1(2):58–60.CrossRef

33.

Jabbar A, Hassanein M, Beshyah SA, Boye KS, Yu M, Babineaux SM. CREED study: Hypoglycaemia during Ramadan in individuals with Type 2 diabetes mellitus from three continents. Diabetes Res Clin Pract. 2017;132:19–26.PubMedCrossRef

34.

Elhadd T, Dabbous Z, Bashir M, Elzouki A, Ghadban W, Baagar K, et al. Incidence of hypoglycaemia in patients with type-2 diabetes taking multiple glucose lowering therapies during Ramadan: the PROFAST Ramadan Study. J Diabetes Metab Disord. 2018;17(2):309–14.PubMedPubMedCentralCrossRef

35.

Vasan S, Thomas N, Bharani AM, Abraham S, Job V, John B, et al. A double-blind, randomized, multicenter study evaluating the effects of pioglitazone in fasting Muslim subjects during Ramadan. Int J Diabetes Dev Ctries. 2006;26(June):70–6.

36.

Cesur M, Corapcioglu D, Gursoy A, Gonen S, Ozduman M, Emral R, et al. A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting. Diabetes Res Clin Pract. 2007;75(2):141–7.PubMedCrossRef

37.

Anwar A, Azmi KN, Hamidon B, Khalid B. An open label comparative study of glimepiride versus repaglinide in type 2 diabetes mellitus Muslim subjects during the month of Ramadan. Med J Malaysia. 2006;61(1):28–35.PubMed

38.

Mafauzy M. Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting. Diabetes Res Clin Pract. 2002;58(1):45–53.PubMedCrossRef

39.

Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA. 2007;298(2):194–206.PubMedCrossRef

40.

Al Sifri S, Basiounny A, Echtay A, Al Omari M, Harman-Boehm I, Kaddaha G, et al. The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial. Int J Clin Pract. 2011;65(11):1132–40.PubMedPubMedCentralCrossRef

41.

Aravind S, Tayeb KA, Ismail SB, Shehadeh N, Kaddaha G, Liu R, et al. Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study. Curr Med Res Opin. 2011;27(6):1237–42.PubMedCrossRef

42.

Bajaj HS, Abouhassan T, Ahsan MR, Arnaout A, Hassanein M, Houlden RL, et al. Diabetes Canada position statement for people with types 1 and 2 diabetes who fast during Ramadan. Can J Diabetes. 2019;43(1):3–12.PubMedCrossRef

43.

Grunberger G. Insulin analogs—are they worth it? Yes! Diabetes Care. 2014;37(6):1767–70.PubMedCrossRef

44.

Akram J, De Verga V, Group TRS. Insulin lispro (Lys (B28), Pro (B29)) in the treatment of diabetes during the fasting month of Ramadan. Diabet Med. 1999;16(10):867–74.CrossRef

45.

Hassanein M, Belhadj M, Abdallah K, Bhattacharya AD, Singh AK, Tayeb K, et al. Management of Type 2 diabetes in Ramadan: Low-ratio premix insulin working group practical advice. Indian journal of endocrinology and metabolism. 2014;18(6):794.PubMedPubMedCentralCrossRef

46.

Salti I, Diabetes, Group RS. Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan. Diabetic medicine. (2009);26(12):1255–61.

47.

Hassanein M, Buyukbese MA, Malek R, Pilorget V, Naqvi M, Berthou B, et al. Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: the observational ORION study. Diabetes Res Clin Pract. 2020;166:108189.PubMedCrossRef

48.

Bellido V, Suarez L, Rodriguez MG, Sanchez C, Dieguez M, Riestra M, et al. Comparison of basal-bolus and premixed insulin regimens in hospitalized patients with type 2 diabetes. Diabetes Care. 2015;38(12):2211–6.PubMedCrossRef

49.

Firouzbakht M, Kiapour A, Jamali B, Kazeminavaei F, Taghlilin F, Gorji AMH. Fasting in pregnancy: A survey of beliefs and manners of Muslim women about Ramadan fasting. Annals of Tropical Medicine and Public Health. 2013;6(5):536.CrossRef

50.

Robinson T, Raisler J. Each one is a doctor for herself": Ramadan fasting among pregnant Muslim women in the United States. Ethn Dis. 2005;15(1 Suppl 1):S1-99.PubMed

51.

Dikensoy E, Balat O, Cebesoy B, Ozkur A, Cicek H, Can G. Effect of fasting during Ramadan on fetal development and maternal health. Journal of Obstetrics and Gynaecology Research. 2008;34(4):494–8.CrossRef

52.

Dikensoy E, Balat O, Cebesoy B, Ozkur A, Cicek H, Can G. The effect of Ramadan fasting on maternal serum lipids, cortisol levels and fetal development. Arch Gynecol Obstet. 2009;279(2):119–23.PubMedCrossRef

53.

Alwasel S, Abotalib Z, Aljarallah J, Osmond C, Alkharaz S, Alhazza I, et al. Secular increase in placental weight in Saudi Arabia. Placenta. 2011;32(5):391–4.PubMedPubMedCentralCrossRef

54.

Afandi BO, Beshyah SA, Hassanein MM, Jabbar A, Khalil AB. The individualization of care for people with diabetes during Ramadan fasting: A narrative review. Ibnosina Journal of Medicine and Biomedical Sciences. 2020;12(2):98.CrossRef

55.

Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in older adults. Diabetes Care. 2012;35(12):2650–64.PubMedCrossRef

56.

van Dijk PT, Meulenberg OG, Van de Sande HJ, Habbema JDF. Falls in dementia patients. Gerontologist. 1993;33(2):200–4.PubMedCrossRef

57.

Irfannuddin I, Santoso B, Zein RH, Naufal AF, editors. The Effect of Aerobic Exercise and Caloric Restriction on Mice’s Brain Tissue PGC-1α Levels and Their Memory Abilities. Journal of Physics: Conference Series; (2019): IOP Publishing.

58.

Laatar R, Borji R, Baccouch R, Zahaf F, Rebai H, Sahli S. Effects of Ramadan fasting on postural balance and attentional capacities in elderly people. J Nutr Health Aging. 2016;20(5):553–60.PubMedCrossRef

59.

Aronson D, Edelman ER. Coronary artery disease and diabetes mellitus. Cardiol Clin. 2014;32(3):439–55.PubMedPubMedCentralCrossRef

60.

Sassi M, Chakroun T, Chouchène S, Hellara I, Boubaker H, Grissa MH, et al. Does Lipid Profile Affect Thrombin Generation During Ramadan Fasting in Patients With Cardiovascular Risks? Clin Appl Thromb Hemost. 2017;23(8):980–6.PubMedCrossRef

61.

Group UKPDS. A 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy (UKPDS 24). Ann Intern Med. (1998);128:165–75.

62.

Hassanien AA, Al-Shaikh F, Vamos EP, Yadegarfar G, Majeed A. Epidemiology of end-stage renal disease in the countries of the Gulf Cooperation Council: a systematic review. JRSM short reports. 2012;3(6):1–21.CrossRef

63.

Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137–47.PubMedCrossRef

64.

El-Wakil HS, Desoky I, Lotfy N, Adam AG. Fasting the month of Ramadan by Muslims: could it be injurious to their kidneys? Saudi Journal of Kidney Diseases and Transplantation. 2007;18(3):349.PubMed

65.

Mbarki H, Tazi N, Najdi A, Tachfouti N, Arrayhani M, Sqalli T. Effects of fasting during Ramadan on renal function of patients with chronic kidney disease. Saudi Journal of Kidney Diseases and Transplantation. 2015;26(2):320.PubMedCrossRef

66.

Bakhit AA, Kurdi AM, Wadera JJ, Alsuwaida AO. Effects of Ramadan fasting on moderate to severe chronic kidney disease: a prospective observational study. Saudi Med J. 2017;38(1):48.PubMedPubMedCentralCrossRef

67.

NasrAllah MM, Osman NA. Fasting during the month of Ramadan among patients with chronic kidney disease: renal and cardiovascular outcomes. Clin Kidney J. 2014;7(4):348–53.PubMedCrossRef

68.

Bragazzi NL. Ramadan fasting and chronic kidney disease: does estimated glomerular filtration rate change after and before Ramadan? Insights from a mini meta-analysis. Int J Nephrol Renov Dis. 2015;8:53.CrossRef

69.

Bernieh B, Al Hakim MR, Boobes Y, Zidan FMA. Fasting Ramadan in chronic kidney disease patients: clinical and biochemical effects. Saudi Journal of Kidney Diseases and Transplantation. 2010;21(5):898.PubMed

Titel: Ramadan fasting and diabetes, latest evidence and technological advancements: 2021 update
verfasst von: Ali Tootee
Bagher Larijan
Publikationsdatum: 02.05.2021
Verlag: Springer International Publishing
Erschienen in: Journal of Diabetes & Metabolic Disorders / Ausgabe 1/2021
Elektronische ISSN: 2251-6581
DOI: https://doi.org/10.1007/s40200-021-00806-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Candida albicans skin infection in patients with type 2 diabetes: a systematic review and meta-analysis

Diabetes and rhino-orbito-cerebral mucormycosis – A deadly duo

Effects of raw red beetroot consumption on metabolic markers and cognitive function in type 2 diabetes patients

Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis

Cardiovascular diseases risk prediction in patients with diabetes: Posthoc analysis from a matched case-control study in Bangladesh